Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Maverick Ventures is the early-stage venture capital arm of Maverick Capital, established in 1993. With over 25 years of investing experience, the firm operates from its offices in San Francisco and New York. Maverick Ventures is distinguished by its evergreen fund structure, which allows for long-term investments without the constraints of a traditional fund lifecycle. This unique approach enables the firm to provide patient capital to early-stage companies in the healthcare and technology sectors. The firm has built a reputation for fostering meaningful partnerships with a limited number of teams each year, ensuring that they can offer substantial support and resources to their portfolio companies. Although specific metrics such as fund size or total assets under management (AUM) are not disclosed, Maverick Ventures collaborates with strategic limited partners, including health systems and industrial conglomerates, to enhance its investment strategy.
Maverick Ventures focuses on early-stage investments in the healthcare, biotech, and technology sectors. The firm typically invests between $1 million and $15 million, with a sweet spot around $5 million, across seed, Series A, and Series B stages. This investment strategy is designed to support innovative companies that are poised to make significant impacts in their respective fields. The evergreen capital structure allows Maverick Ventures to provide patient capital, which is particularly beneficial for startups that require time to develop their products and market presence without the pressure of imminent returns. The firm seeks to partner with founders who are passionate about their vision and are committed to long-term growth. By leveraging Maverick Capital's extensive experience in public markets, Maverick Ventures offers a unique downstream perspective that enhances its investment approach and provides cross-stage support for portfolio companies.
Maverick Ventures boasts a diverse portfolio of early-stage healthcare and technology companies, reflecting its commitment to innovation and growth in these sectors. Notable investments include BioCatch, a leader in behavioral biometrics; Cityblock Health, which focuses on providing healthcare services to underserved communities; Hims, a telehealth company; and OpenAI, a prominent artificial intelligence research organization. These investments highlight Maverick Ventures' strategy of backing companies that are not only technologically advanced but also have the potential to create significant social impact. The firm's affiliation with Maverick Capital enhances its portfolio by providing access to a broader investment platform and resources, enabling portfolio companies to thrive in competitive markets.
Maverick Ventures invests in early-stage companies across seed, Series A, and Series B stages. This approach allows them to support startups at critical points in their development.
The firm primarily focuses on the healthcare, biotech, and technology sectors. This specialization enables them to leverage their expertise and network to support innovative companies in these fields.
Maverick Ventures typically invests between $1 million and $15 million in their portfolio companies, with a sweet spot around $5 million. This range allows them to provide substantial support to early-stage ventures.
Maverick Ventures primarily invests in North America, focusing on companies based in the United States. Their geographic focus aligns with their strategy of supporting innovative healthcare and technology startups.
While specific details about the application process are not provided, it is advisable for founders to reach out directly to the firm to inquire about pitching opportunities and any preferred formats.
Maverick Ventures emphasizes collaboration with its portfolio companies, offering support through its extensive network and the resources available from Maverick Capital. This includes insights from public markets and strategic partnerships.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.